Last updated: 2026-10-02 13:32:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Autonomix Medical, Inc. (AMIX) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $3.97, with a market capitalization of $7.51M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.44 to $32.55. This page covers its latest market performance, valuation, price trends and company information.
$7.51M | |
$3.91 | |
$3,192.00 | |
$2.44 | |
$3.92 | |
2.05M | |
4.53M | |
-- | |
$32.55 | |
$2.44 | |
-- | |
-- |
Autonomix Medical, Inc. (AMIX) is currently trading at $3.97 as of 2026-10-02 13:31:00, up 1.38% ($0.05) from the previous close of $3.92
During today's regular trading session, AMIX has traded between $2.44 and $3,192.00, with a trading volume of 2.05M shares. The current price is near the lower end of today's range.
Over the past seven days, Autonomix Medical, Inc. (AMIX) moved from $3.98 to $3.97, representing a decline of 0.15% ($0.01).
The stock traded between $3.60 and $4.44 during the period. The latest price is near the middle of the 7-day range, indicating range-bound.
The average daily volume was 146.70 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 5.1%
AMIX is currently trading at $3.97, placing it 5.1% of the way from its 52-week low of $2.44 to its 52-week high of $32.55. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Autonomix Medical Inc is a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system. Its platform is designed to integrate high-sensitivity neural signal detection with targeted radiofrequency (RF) ablation, enabling a sense, treat, verify approach for nerve-targeted therapies. The Company operates in one reportable segment, which is advancing the development of technologies for sensing and treating disorders relating to the nervous system. It is initially focused on developing the technology for patients with pancreatic cancer and believes the technology has the potential to address several indications, including chronic pain management, hypertension, cardiovascular disease, and other nerve-related disorders.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 11 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Autonomix Medical, Inc. (AMIX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.